- American City Business Journals•6 hours ago
Stereotaxis Inc. has secured $24 million in equity financing and is retiring $13 million in debt. The St. Louis-based maker of medical devices for treating cardiac arrhythmias announced Tuesday that it will receive a $24 million upfront investment upon the issuance of preferred stock with a conversion price of 65 cents, a 10 percent premium to the stock’s closing price Monday. Stereotaxis could receive up to an additional $25.8 million in the future upon the exercise of warrants.
- Zacks•12 hours ago
On Sep 23, we issued an updated research report on Sunnyvale, CA???based Accuray Inc. (ARAY), a leading developer and designer of radiosurgery and radiation therapy systems for the treatment of tumors.
Masimo Corporation (MASI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||19.00 x 500|
|Ask||64.99 x 100|
|Day's Range||58.88 - 60.05|
|52wk Range||33.03 - 60.52|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||31.27|
|Avg Vol (3m)||350,398|
|Dividend & Yield||0.00 (0.00%)|